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Detailed Methods  
 
Cell culture and transfection 
HEK293 cells were cultured in Dulbecco’s modified Eagle medium supplemented 
with 10% (v/v) foetal bovine serum, 2 mmol/L glutamine and 100 µg/ml 
penicillin/streptomycin (LifeTech).  Cells were incubated at 37°C, 5% CO2 and 80-90% 
humidity at a density of 2 x 105 per 100 mmol/L plate (60 cm2) 24 hours prior to transfection 
with pcDNA3/eGFP-hRyR2 (6 µg per 1 x 105 cells). After overnight incubation, transfected 
cells were treated with 2 mmol/L sodium butyrate for a further 24 hours before assessment 
of expression (by eGFP visualisation), harvesting by centrifugation (1500 rpm, AllegraR, 
Beckman) and storage at -80°C.  
 
Purification of recombinant hRyR2 channels 
Frozen cell pellets (typically ~50 x 106 cells) were lysed on ice in a hypo-osmotic 
buffer (20 mmol/L Tris-HCl, 5 mmol/L EDTA; pH 7.4) containing protease inhibitor cocktail 
(Roche), by passing them approximately 20 times through a 23G needle. Unbroken cells 
and nuclei were removed by low speed centrifugation (1500 rpm, 4°C, AllegraR, Beckman) 
and the resulting lysate was subjected to a high-speed centrifugation (100,000 g, 90 minutes, 
4°C, Optima L-90K, Beckman) to collect the microsomal membranes. Solubilization of these 
membranes was carried out (at a concentration of 2.5 mg/ml) in a solution containing 1 
mol/L NaCl, 0.15 mmol/L CaCl2, 0.1 mmol/L EGTA, 25 mmol/L PIPES, 0.6% (w/v) CHAPS 
and 0.3% (w/v) phosphatidylcholine, with protease inhibitor cocktail (Sigma) at 4°C. 
Insoluble material was removed by centrifugation (15,000 g, 1 hour at 4°C) and the 
supernatant loaded onto a 5-30% (w/v) continuous sucrose gradient.  Fractions containing 
channel proteins were collected after overnight (18 hours) centrifugation at 4°C and stored at 
-80°C until use. 
 
Assessment of hRyR2 tetramer expression and function. 
 Expression of hRyR2 from ER membranes (50µg) and solubilised sucrose fractions 
was assessed using immunoblotting as described1 using an anti-eGFP primary antibody (B-
2, Santa Cruz). Sucrose fractions were concentrated (from 500 to 100 µl) using Amicon Ultra 
100K centrifugal filters, before loading (15 µl). Ca2+ activation was measured using [3H]-
ryanodine binding to ER membranes (100 µg) from transfected HEK293 cells and was 
carried out as reported previously.2 The binding of [3H]-ryanodine to RyR2 is an indirect 
measure of channel open probability (Po) in populations of channels as the site of interaction 
is only accessible in the open state of the channel.3 The dependence of single channel Po 
on cytosolic Ca2+ can be measured directly by varying the buffered free Ca2+ concentration 
of the cis chamber, this was carried out as reported previously.4 
 
Isolation of SR K+ channels 
Light and heavy SR membrane vesicle fractions were prepared by differential 
centrifugation of cardiac muscle homogenates derived from adult male Sprague-Dawley rats 
using protocols described previously.5 All procedures were carried out according to 
Institutional and UK ethical guidelines. 
 
Effective concentration range of flecainide 
Flecainide has a pKa of 9.3 so that at pH 7.4 99% of flecainide molecules will be 
cationic with the remaining 1% uncharged. It has been suggested that the intracellular 
effects of flecainide are best observed after incubation with the drug6,7 and that flecainide 
can also accumulate in the heart.8,9 However the cited studies give no indication of where in 
the heart, or how, accumulation might occur and provide no information on achievable 
intracellular concentrations. Over a period of time the flecainide concentrations in the 
extracellular space, the cytosol and the SR lumen should equilibrate, however cytosolic and 
luminal concentrations will never exceed the extracellular concentration unless the molecule 
is bound with high affinity to sites within these compartments. Flecainide, bound to 
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hypothetical high affinity intracellular sites, would not be free to interact with sarcolemmal or 
SR membrane channels.  
In the studies reported in this communication we have used intracellular flecainide 
concentrations several fold higher than the extracellular concentrations necessary to inhibit 
Ca2+ waves in isolated cardiac myocytes, to enable us to establish the mechanisms of action 
of flecainide on intracellular membrane proteins responsible for the regulation of SR Ca2+ 
release.  
 
Conditions for recording single hRyR2 channels 
Single hRyR2 channels were incorporated into bilayers formed using a suspension of 
phosphatidylethanolamine (Avanti Polar Lipids) in n-decane (35 mg/ml).  Bilayers were 
formed in a solution containing 610 mmol/L KCl, 20 mmol/L HEPES (pH 7.4) in both cis (0.5 
ml) and trans (1 ml) chambers. Channel incorporation from the cis chamber was facilitated 
by the introduction of an osmotic gradient (using 200 µl 3 mol/L KCl). On stirring, hRyR2 
incorporates in a fixed orientation such that the cis chamber corresponds to the cytosolic 
side of the channel and the trans chamber to the luminal side. After channel incorporation, 
symmetrical ionic conditions were re-instated by perfusion of the cis chamber with a 610 
mmol/L KCl, 20 mmol/L HEPES (pH 7.4) solution. All experiments were carried out at room 
temperature (20-22°C).  
 The effects of flecainide, propafenone and tetracaine (Sigma) were determined after 
addition of the drug to either cis or trans chambers at concentrations indicated in the text. 
We optimized the quantification of block by using conditions that maximize the open duration 
of the channel i.e. high permeant ion concentration (610 mmol/L K+) in the presence of 20 
µmol/L EMD 41000, a RyR2 agonist shown previously to act via the caffeine-binding site.10 
In competition assays, tetrapentylammonium (TPeA) (Sigma) was added to the cis chamber 
at the concentrations stated.  
 The ability of cytosolic flecainide to block RyR2 was also determined at 0 mV in the 
presence of an ionic gradient (210 mmol/L KCl cis, 850 mmol/L trans) with cytosolic Ca2+ 
(approx. 1 µmol/L free4) as the only activating ligand.  
 The effect of flecainide on hRyR2 gating was determined with cytosolic Ca2+ as the 
sole activating ligand at -40 mV (current flowing in the physiologically relevant, luminal-to-
cytosolic direction) in the presence of various concentrations of cytosolic flecainide.  
 The potential effect of flecainide on hRyR2 channel function was also assessed in 
cell-like salt solutions (with Ca2+ as the permeant ion) as follows: Bilayers were formed in 
symmetrical 120 mmol/L KCl and channels were incorporated using an osmotic gradient as 
before. After re-instating symmetrical ionic conditions (120 mmol/L KCl), 1 mmol/L MgCl2 
and 5 mmol/L CaCl2 were added to the trans chamber, while the solution in the cis chamber 
was adjusted to contain 10 µmol/L free Ca2+ (using CaCl2), 1 mmol/L free Mg2+ and 5 
mmol/L total ATP (using MgCl2 and MgATP). Free ion concentrations were calculated using 
MaxChelator (http://web.stanford.edu/~cpatton/webmaxcS.htm). Recordings were at 0 mV 
holding potential and the current recorded was due to the net movement of Ca2+ ions from 
the luminal to the cytosolic side of the channel.  
 
Conditions for recording single SR K+ channels 
LSR vesicles were fused to PE bilayers in 75 mmol/L K2SO4 (10 mmol/L HEPES, pH 
7.4) using osmotic gradients. The hyperosmotic cis chamber was perfused out following 
successful channel incorporation. Recordings were made in the absence and presence of 
symmetrical flecainide at a cis holding potential of 40 mV with polarity alternating every 30 
seconds. Block by succinyl choline was used at the end of each experiment to confirm 
channel identity. Data were filtered at 1 kHz and open probability and mean dwell times of 
the full conductance state were determined using TACx4.1.5 (Bruxton).  
 
Analysis of single channel recordings 
Single channel currents were low-pass filtered at 5 kHz with an 8-pole Bessel filter 
then digitized at 20 kHz with a PCI-6036E AD board (National Instruments).  Acquire 5.0.1. 
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(Bruxton) was used for viewing and acquisition of the single channel traces. Data analysis 
was carried out using QuB v2.0.0.13.  www.qub.buffalo.edu).11 Single channel traces of 2-3 
minutes (containing >3000 events) were idealized using the Segmental K-means (SKM) 
algorithm12 based on Hidden Markov Models (HMM) and a dead time of 75-120 µs was 
imposed. In traces where substate block was detected (by evaluation of the amplitude 
histogram), idealization was carried out using a three state (closed (C) ↔ open (O) ↔ 
blocked (B)) scheme.  QuB can accurately distinguish between blocked and closed levels 
(Online Figure I) and idealization using this scheme resulted in the calculation of mean 
amplitudes, open (Po), blocked (Pb) and closed (Pc) probabilities and mean open (To), 
blocked (Tb) and closed (Tc) times. In all other instances where block was not observed a 2-
state (C↔O) scheme was used for idealization, which yielded amplitude, Po, To and Tc as 
previously.4  Rates of flecainide association (Kon) and disassociation (Koff) were calculated by 
plotting the reciprocal of To and Tb, respectively against drug concentration or voltage.  
 Maximal counter current through hRyR2 in the absence of flecainide was estimated 
by the product of open state amplitude and To over 30 seconds of channel recording in the 
presence of EMD 41000 (designated 100%). The counter current in the presence of 
flecainide was estimated by the sum of (open state amplitude x To) and (blocked state 
amplitude x Tb) over 30 seconds of channel recording, and expressed as a proportion of 
counter current in the absence of flecainide. 
 
Ventricular myocyte isolation, permeabilisation and imaging of Ca2+ sparks  
All animal surgical procedures and peri-operative management were carried out in 
accordance with the Guide for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH Publication, 8th Edition, 2011) under assurance number 
A5634-01. Imperial College Ethical Review Committee authorized the project licence.  Rats 
were sacrificed by cervical dislocation following exposure to 5% isoflurane until righting 
reflex was lost. Cardiac myocytes were enzymatically isolated from the left ventricle of 
healthy adult male Sprague-Dawley rats by Langendorff perfusion.13 A gravity driven 
superfusion system with a low volume chamber (Warner RC-24N) was used to allow rapid 
solution exchanges at 37°C. Cells were attached to coverslips using mouse laminin (Sigma-
Aldrich) and superfused with a solution containing 90 mmol/L KCl, 10 mmol/L NaCl, 5 
mmol/L (total) K2ATP, 10 mmol/L creatine phosphate, 5.5 mmol/L (total) MgCl2, 0.05 mmol/L 
K2EGTA, 0.02 mmol/L CaCl2. The fluorophore used was 5 µmol/L fluo5F pentapotassium 
salt (LifeTech) for waves and fluo4 pentapotassium salt for sparks. Cells were permeabilised 
in this solution containing 0.1 mg/ml escin (Sigma) for ~2 minutes, until Ca2+ waves were 
observed (denoting permeabilisation), whereupon cells were superfused with the original 
imaging solution containing varying concentrations of flecainide (0, 5 or 25 µmol/L). The 
same cell was imaged in the absence of drug (0), or following the addition of 5- and 25 
µmol/L flecainide using a cross-over protocol as described.14 Sparks were assessed using 
line-scan images collected at a rate of 500 lines per second and detected using SparkMaster 
as previously described.14-16 
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Supplemental Figures 
 
 
 
Online Figure I 
Assessment of hRyR2 channel expression and function 
A. Full-length recombinant hRyR2 is detected as a discrete band with few breakdown 
products in microsomes (50µg) from 5 different transfections (labelled 1-5). B. Isolation of 
tetrameric hRyR2 channels (~2.2 MDa) with no breakdown products in a fraction containing 
approximately 30% sucrose, following sucrose density gradient separation (40-19% fractions 
shown here, M = molecular weight marker). Recombinant channels are functional both 
before and after purification: C. hRyR2s from microsomes demonstrated typical Ca2+ 
activation, measured using [3H]-ryanodine binding (as disintegrations per minute (dpm), see 
Methods) with an EC50 of 0.58 ± 0.27µmol/L (n=5). D. Ca2+ activation curve for a 
representative individual purified hRyR2 channel which activated similarly (EC50 = 0.41 
µmol/L). It should be noted that both methods demonstrate activation over the range of Ca2+ 
concentrations compatible with the variation in cytosolic Ca2+ expected during cardiac 
excitation-contraction coupling. 
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Online Figure II 
Block of the cytosolic-to-luminal ion flux through hRyR2 by flecainide can be 
described by a three-state scheme. 
A. Representative single channel traces recorded at + 40 mV showing flecainide (50 µmol/L) 
block idealized using the SKM function of QuB (the portion of trace underlined in blue is 
expanded below). These events were best described by the closed (C) to open (O) to 
blocked (B) transitions represented by the model shown (and labelled on the trace). B. Dwell 
time histograms (plotted as log10 duration vs square root of counts/total) for closed, open 
and blocked states (represented by the black, red and blue curves respectively) can each be 
described by a single exponential. 
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Online Figure III 
Flecainide competes with TPeA to bind at a site in the cytosolic vestibule of hRyR2 
A. Representative single channel traces recorded at +40 mV in the presence of 20 µmol/L 
flecainide and increasing concentrations of TPeA. Openings are downwards from the closed 
level (black line) with flecainide and TPeA blocked states shown in red and blue respectively. 
Current amplitude histograms below show that with increasing concentration of TPeA the 
proportion of blocking events due to flecainide (red arrow) decreases and those due to TPeA 
(blue arrow) increases. These data (n=3) are represented graphically in B. In earlier 
investigations it has been established that block of RyR2 by cytosolic TPeA involves 
interactions between the cation and residues of the cavity-lining helices of the channel PFR. 
Direct competition in the ability of flecainide and TPeA to block hRyR2 identifies the cytosolic 
vestibule of the hRyR2 PFR as the binding site for flecainide during block. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   CIRCRES/2014/305347/R2	  	  
	   9	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure IV 
Cytosolic propafenone blocks cytosolic-to-luminal but not luminal-to-cytosolic flux of 
cations through hRyR2 channels 
A. Current fluctuations through a representative hRyR2 channel at a holding potential of +40 
mV prior to, and following the addition of, increasing concentrations of propafenone to the 
cytosolic side of the channel (closed level indicated by the solid line at the left of each trace). 
Under these conditions the net cation flux through the channel is cytosolic-to-luminal. As is 
the case with flecainide (see Figure 1), propafenone induces short-lived, but clearly resolved, 
transitions from the open state to a reduced conductance state (marked with a dotted line). 
The residual current that continues to flow during propafenone block is larger than that seen 
with flecainide (31.23 ± 0.27% of full conductance) and does not vary significantly with 
blocker concentration. B. Quantification of the decrease in Po with increasing propafenone 
concentration (n=5). C. Consistent with our observations with flecainide, when net cation flux 
through RyR2 is reversed to the physiologically relevant direction by imposing a holding 
potential of -40 mV, propafenone, at concentrations up to 50 µmol/L, produces no significant 
reduction in Po, quantified in D. 
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Online Figure V 
Cytosolic tetracaine inhibits both cytosolic-to-luminal and luminal-to-cytosolic flux of 
cations through hRyR2 channels 
A. Current fluctuations through a representative hRyR2 channel at a holding potential of +40 
mV prior to, and following the addition of, increasing concentrations of tetracaine to the 
cytosolic side of the channel (closed level indicated by the solid line at the left of each trace). 
Under these conditions, tetracaine reduces RyR2 Po in a concentration-dependent manner, 
as quantified in B. In contrast to flecainide and propafenone, the reduction in RyR2 Po 
induced by tetracaine results from increases in the duration of closed events.  C. Unlike 
flecainide and propafenone, high concentrations of cytosolic tetracaine significantly reduce 
RyR2 Po when cation flux through the channel is in the physiologically relevant direction  (-
40mV), quantified in D. 	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Online Figure VI 
Mechanism of interaction of flecainide with hRyR2 is unaltered in the N4104K CPVT 
mutant channel 
A. Representative single channel traces recorded at -/+40 mV, where openings are upwards 
or downwards from the close level (black line), respectively. As for the WT channel, block by 
flecainide only occurs at positive holding potentials (when ionic flux is in the cytosolic-to-
luminal direction). B. Association (kon) and dissociation (koff) rates of flecainide interaction 
with N4104K channels. 
 
 
 
 
 
